Celldex Therapeutics Presents Positive Data from
- Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential......
Celldex Therapeutics Announces Upcoming Presentation of
Company to host webcast on Sunday, February 26 at 4:00 pm CT/5:00 pm ET......